Discover how the latest breakthrough in breast cancer prognosis leverages the diversity within tumors themselves, potentially revolutionizing patient outcomes and treatment strategies.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer.
Zilenaite-Petrulaitiene et al., Virchows Arch 2024
DOI: 10.1007/s00428-024-03737-4
Study Highlights:
- New Information: This study introduces the use of digital image analysis (DIA) and computational pathology to quantify intratumoral heterogeneity (ITH) in ER-positive, HER2-negative breast cancer, focusing on the prognostic value of ITH indicators.
- Importance: The research highlights the significance of ITH, specifically the spatial distribution of Ki67-positive cells, as an independent predictor of breast cancer-specific survival (BCSS), which could lead to improved risk assessment.
- Contribution to Literature: The study provides evidence that Ki67 entropy, a measure of the spatial disarrangement of tumor proliferation, is a more reliable prognostic indicator than the proliferation rate itself, challenging the current visual scoring methods used by pathologists.
Results Summary:
The study analyzed whole slide images from 254 ER-positive, HER2-negative breast cancer patients. Haralick’s texture entropy of Ki67-positive cells was found to be an independent predictor of worse BCSS, with a hazard ratio of 2.64 (p=0.0049). This finding suggests that the spatial arrangement of proliferating tumor cells (Ki67 entropy) is more prognostically significant than the actual rate of proliferation. Additionally, lymph node involvement was also identified as an independent predictor with a hazard ratio of 2.26 (p=0.0195).
The study underscores the potential of computational methods to capture subvisual ITH properties that are not accounted for in traditional pathology assessments, advocating for the integration of DIA in clinical practice.
